Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 26, 208-211, February 1, 1966]
© 1966 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kidd, J. G.
Right arrow Articles by Sobin, L. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kidd, J. G.
Right arrow Articles by Sobin, L. H.

The Incorporation of L-Asparagine-14C by Lymphoma 6C3HED Cells: Its Inhibition by Guinea Pig Serum1

John G. Kidd and Leslie H. Sobin

Department of Pathology, The New York Hospital-Cornell Medical Center, New York, New York

Lymphoma 6C3HED-OG cells (of Gardner's original line), growing intraperitoneally in susceptible C3H hosts, were found to take up L-asparagine-14C readily from subcutaneous depots. Further, the incorporation of L-asparagine-14C was almost completely prevented in vivo by the i.p. injection of heated serum procured from normal guinea pigs, which is known to exert antilymphoma effects on the OG cells and to contain active asparaginase even after heating at 56°C for 30 min. An opposite effect was obtained with normal horse serum, which does not have antilymphoma effects and is known to be devoid of asparaginase. By contrast, under identical conditions in vivo, the 6C3HED cells failed to take up L-aspartic acid-14C, or did so only poorly.

In vitro, the Lymphoma 6C3HED-OG cells also took up L-asparagine-14C avidly. Again, the incorporation of L-asparagine-14C was almost completely prevented by guinea pig serum, either unheated or heated at 56°C for 30 min, whereas horse serum had an enhancing effect. Similarly, too, the OG cells failed to take up L-aspartic acid-14C in vitro, or did so only sparingly.

The cells of Lymphoma 6C3HED-RG1, which, in contrast to the OG cells, are not susceptible to the antilymphoma effects of guinea pig serum in vivo and do not depend upon extrinsic L-asparagine for growth in vitro, also regularly incorporated L-asparagine-14C from subcutaneous depots in vivo. Further, guinea pig serum inhibited incorporation under such circumstances, and the RG1 cells did not take up notable amounts of L-aspartic acid in vitro.

The implications of the findings are briefly considered in relation to the metabolism of asparagine by Lymphoma 6C3HED cells of the 2 types and to the antilymphoma effects of heated guinea pig serum.

1 Supported in part by grants from the American Cancer Society, the National Cancer Institute (Grant CA-6833), and Mr. John W. O'Boyle.

Received 6/16/65.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1966 by the American Association for Cancer Research.